Cargando…
Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function
SUMMARY: The purpose of this study was to evaluate the measurement properties of the Osteoporosis Assessment Questionnaire-Physical Functioning (OPAQ-PF). Based on this study, the OPAQ-PF has confirmed unidimensionality and acceptable reliability, construct validity, and sensitivity to change in a r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023015/ https://www.ncbi.nlm.nih.gov/pubmed/24737386 http://dx.doi.org/10.1007/s00198-014-2695-4 |
_version_ | 1782316492288688128 |
---|---|
author | Nixon, A. Kerr, C. Doll, H. Naegeli, A. N. Shingler, S. L. Breheny, K. Burge, R. Gold, D. T. Silverman, S. |
author_facet | Nixon, A. Kerr, C. Doll, H. Naegeli, A. N. Shingler, S. L. Breheny, K. Burge, R. Gold, D. T. Silverman, S. |
author_sort | Nixon, A. |
collection | PubMed |
description | SUMMARY: The purpose of this study was to evaluate the measurement properties of the Osteoporosis Assessment Questionnaire-Physical Functioning (OPAQ-PF). Based on this study, the OPAQ-PF has confirmed unidimensionality and acceptable reliability, construct validity, and sensitivity to change in a recent fracture/no recent fracture osteoporosis sample. METHODS: Dimensionality was established through exploratory and confirmatory factor analysis. Patients completed three patient reported outcome (PRO) measures and four performance-based measures (PBMs) at baseline to enable an evaluation of construct validity. Patients without a recent fracture completed the OPAQ-PF 2 weeks after baseline to enable an evaluation of test–retest reliability. Ability to detect change and interpretation of change were investigated following completion of the OPAQ-PF 12 and 24 weeks postbaseline by patients with a recent fracture. RESULTS: A prospective psychometric validation study in 144 postmenopausal women, with moderate to severe osteoporosis, 37 of whom had experienced a recent fragility fracture (<6 weeks). Unidimensionality was established for the OPAQ-PF by factor analysis. The OPAQ-PF had good internal consistency (α = 0.974) and test–retest reliability (mean intraclass correlation coefficient (ICC) 0.993. The OPAQ-PF differentiated between patients with/without recent fracture, and by severity of osteoarthritis; it correlated strongly with hypothesized-related scales and PBMs (r > 0.3, p < 0.001). Ability to detect change was established with high correlations between changes in OPAQ-PF score and changes in global concept scores in recent fracture patients (r ≥ 0.6, 24-week change). Effect size of change on OPAQ-PF score increased by level of global change (p < 0.001). Anchor-based methods identified an OPAQ-PF change of 10 at an individual patient level and 20 at a group level as meaningful to patients. CONCLUSIONS: The OPAQ-PF has confirmed unidimensionality and acceptable reliability, construct validity, and sensitivity to change in a recent fracture/no recent fracture osteoporosis sample. |
format | Online Article Text |
id | pubmed-4023015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-40230152014-05-16 Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function Nixon, A. Kerr, C. Doll, H. Naegeli, A. N. Shingler, S. L. Breheny, K. Burge, R. Gold, D. T. Silverman, S. Osteoporos Int Original Article SUMMARY: The purpose of this study was to evaluate the measurement properties of the Osteoporosis Assessment Questionnaire-Physical Functioning (OPAQ-PF). Based on this study, the OPAQ-PF has confirmed unidimensionality and acceptable reliability, construct validity, and sensitivity to change in a recent fracture/no recent fracture osteoporosis sample. METHODS: Dimensionality was established through exploratory and confirmatory factor analysis. Patients completed three patient reported outcome (PRO) measures and four performance-based measures (PBMs) at baseline to enable an evaluation of construct validity. Patients without a recent fracture completed the OPAQ-PF 2 weeks after baseline to enable an evaluation of test–retest reliability. Ability to detect change and interpretation of change were investigated following completion of the OPAQ-PF 12 and 24 weeks postbaseline by patients with a recent fracture. RESULTS: A prospective psychometric validation study in 144 postmenopausal women, with moderate to severe osteoporosis, 37 of whom had experienced a recent fragility fracture (<6 weeks). Unidimensionality was established for the OPAQ-PF by factor analysis. The OPAQ-PF had good internal consistency (α = 0.974) and test–retest reliability (mean intraclass correlation coefficient (ICC) 0.993. The OPAQ-PF differentiated between patients with/without recent fracture, and by severity of osteoarthritis; it correlated strongly with hypothesized-related scales and PBMs (r > 0.3, p < 0.001). Ability to detect change was established with high correlations between changes in OPAQ-PF score and changes in global concept scores in recent fracture patients (r ≥ 0.6, 24-week change). Effect size of change on OPAQ-PF score increased by level of global change (p < 0.001). Anchor-based methods identified an OPAQ-PF change of 10 at an individual patient level and 20 at a group level as meaningful to patients. CONCLUSIONS: The OPAQ-PF has confirmed unidimensionality and acceptable reliability, construct validity, and sensitivity to change in a recent fracture/no recent fracture osteoporosis sample. Springer London 2014-04-16 2014 /pmc/articles/PMC4023015/ /pubmed/24737386 http://dx.doi.org/10.1007/s00198-014-2695-4 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Nixon, A. Kerr, C. Doll, H. Naegeli, A. N. Shingler, S. L. Breheny, K. Burge, R. Gold, D. T. Silverman, S. Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title | Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title_full | Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title_fullStr | Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title_full_unstemmed | Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title_short | Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
title_sort | osteoporosis assessment questionnaire-physical function (opaq-pf): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023015/ https://www.ncbi.nlm.nih.gov/pubmed/24737386 http://dx.doi.org/10.1007/s00198-014-2695-4 |
work_keys_str_mv | AT nixona osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT kerrc osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT dollh osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT naegelian osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT shinglersl osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT brehenyk osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT burger osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT golddt osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction AT silvermans osteoporosisassessmentquestionnairephysicalfunctionopaqpfapsychometricallyvalidatedosteoporosistargetedpatientreportedoutcomemeasureofdailyactivitiesofphysicalfunction |